The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of inavolisib-associated hyperglycemia in metastatic hormone receptor–positive (HR+) breast cancer.
 
Sherry Shen
Honoraria - Curio Science; MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; GE Healthcare
Research Funding - Merck (Inst); Sermonix Pharmaceuticals (Inst); SynDevRx (Inst)
 
Daniella Audi Blotta
No Relationships to Disclose
 
Maria Bromberg
No Relationships to Disclose
 
Yuan Chen
No Relationships to Disclose
 
Ya Haddy Sallah
No Relationships to Disclose
 
Jimmitti Teysir
No Relationships to Disclose
 
Komal Jhaveri
Consulting or Advisory Role - Abbvie; Arivinas; AstraZeneca; BeOne Therapeutics; Bicycle Therapeutics; Biotheranostics; BluePrint Medicines; Bridge Bio Oncology and Rayzebio; Bristol-Myers Squibb; ConcertAI; Daiichi Sankyo; Eisai; Genentech; Gilead Sciences; Halda Therapeutics; Lilly; Mersana; natera; Novartis; Olema Pharmaceuticals; Pfizer; Precede Bio; RAYZEBIO; Relay Therapeutics; Sanofi; Scorpion Therapeutics; Seagen; Zymeworks
Research Funding - AstraZeneca (Inst); Blueprint Medicines (Inst); Bridge Bio Oncology Therapeutics; Context Therapeutics (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck; Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); RayzeBio (Inst); Scorpion Therapeutics (Inst); VelosBio/Merck (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; Gilead Sciences; Intellisphere; Jounce Therapeutics; Lilly; Pfizer; Taiho Pharmaceutical